This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 1. Distribution of cancer targets for Category I genetic tests
| Cancer |
# of tests |
% of total |
| Breast |
12 |
24% |
| Prostate |
10 |
15% |
| Lung |
10 |
15% |
| Colorectal |
10 |
18% |
| Pancreas |
0 |
0% |
| Ovarian |
4 |
6% |
| Esophagus |
0 |
0% |
| Liver |
1 |
1% |
| Lymphoma |
0 |
0% |
| Leukemia |
2 |
3% |
| Other |
12 |
19% |
| Total indications |
*61 |
100% |
* Total # of indications may be greater than total # of tests in the database because some tests may have multiple indications.
Return to Document